What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.

Rieke E Alten Juan Carlos Nieto-Gonzalez Peggy JacquesCarlomaurizio MontecuccoRobert MootsHelga RadnerHarald E VonkemanSebastian HeidenreichChiara WhichelloNicolas KrucienKatrien Van Beneden

Published in: RMD open (2024)

Treatment preferences of patients with RA were individual-specific, but driven by benefits and risks, with no single attribute dominating the decision-making.

Keyphrases

rheumatoid arthritis patients
decision making
disease activity
rheumatoid arthritis
systemic lupus erythematosus
risk assessment
systemic sclerosis
climate change
interstitial lung disease
idiopathic pulmonary fibrosis